Drug Shortage Report for SDZ CELECOXIB
Report ID | 2875 |
Drug Identification Number | 02442647 |
Brand name | SDZ CELECOXIB |
Common or Proper name | CELECOXIB |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CELECOXIB |
Strength(s) | 200MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | M01AH |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-03-14 |
Estimated end date | 2017-08-18 |
Actual end date | 2017-05-05 |
Shortage status | Resolved |
Updated date | 2017-05-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2017-05-08 | French | Compare |
v3 | 2017-05-08 | English | Compare |
v2 | 2017-03-15 | French | Compare |
v1 | 2017-03-15 | English | Compare |
Showing 1 to 4 of 4